Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus immunomonitoring in healthy volunteers
NL-OMON45922Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Jun 2018
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tacrolimus in organ allograft rejection, sponsored by Centre for Human Drug Research. Primary endpoints: Serious and non-serious adverse events, Laboratory safety and vital signs and 6 more. Started Jun 2018; status: active, not recruiting.
02
Drugs
tacrolimus
03
Conditions
organ allograft rejection
Beyond the preview
Go deeper on NL-OMON45922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45922.